NVIDIA Offers Free Access to Genome-Sequencing Software to COVID-19 Researchers

GPU maker NVIDIA hopes to accelerate virus research by giving away free licenses of Parabricks software

GPU maker NVIDIA hopes to accelerate virus research by giving away free licenses of Parabricks software

GPU maker NVIDIA to give away free licenses of genomic analysis software to Coronavirus researchers. Image by Lete Linforth, Pixelbay


On March 19, GPU maker NVIDIA announced it's giving away free 90-day licenses of its genome-sequencing software Parabricks to researchers in the fight against Coronavirus.

According to the company's blog post, “In response to the current pandemic, NVIDIA is sharing tools with researchers that can accelerate their race to understand the novel coronavirus and help inform a response.”

To gain access, researchers need to fill out a request form.

Parabricks is a GPU-accelerated genome analysis toolkit developed by the Ann Arbor, Michigan-based firm Parabricks. The firm was acquired by NVIDIA for an undisclosed amount last December.

Because the software takes advantages of the computing cores in the GPU, “data that once took days to analyze can now be done in under an hour,” NVIDIA says.

With compute-intensive software such as Parabricks, the massive number of computing cores assigned to the job can dramatically shorten the completion time. Hence, cloud-hosted or on-demand GPU computing resources are a critical component of the application.

In the blog post announcing the giveaway, NVIDIA says, “We’re in discussions with cloud service providers and supercomputing centers to provide compute resources and access to Parabricks on their platforms.”

More NVIDIA Coverage

Share This Article

Subscribe to our FREE magazine, FREE email newsletters or both!

Join over 90,000 engineering professionals who get fresh engineering news as soon as it is published.


About the Author

Kenneth Wong's avatar
Kenneth Wong

Kenneth Wong is Digital Engineering’s resident blogger and senior editor. Email him at [email protected] or share your thoughts on this article at digitaleng.news/facebook.

      Follow DE
#23803